Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

Affiliations

• ¹ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden [email protected].
• ² GlaxoSmithKline, Research Triangle Park, NC, USA.
• ³ Cancer Therapy Research Center, San Antonio, TX, USA (formerly Roswell Park Cancer Institute, Buffalo, NY, USA).
• ⁴ UCSD Moores Cancer Center, La Jolla, CA, USA.
• ⁵ Faculty Hospital Brno, Dept of Internal Medicine/Hemato-Oncology, Czech Republic.
• ⁶ Universitätsklinikum Ulm, Department of Internal Medicine III, Germany.
• ⁷ Center for Clinical Haematology, Nottingham University Hospitals, UK.
• ⁸ Department of Hematology, Medical University of Gdansk, Poland.
• ⁹ Weill Cornell Medical College, Division of Hematology/Oncology, New York, NY, USA.
• ¹⁰ Department of Hematology, Medical University of Lodz, Poland.
• ¹¹ St James' Institute of Oncology, St James' University Hospital, Leeds, UK.
• ¹² First Faculty of Medicine, Charles University General Hospital, Prague, Czech Republic.
• ¹³ The Ernest and Helen Scott Haematological Research Institute, University of Leicester, UK.
• ¹⁴ Klinika Hematologii CMUJ, Krakow, Poland.
• ¹⁵ University Hospital Kralovske Vinohrady, Department of Clinical Hematology, Prague, Czech Republic.
• ¹⁶ GlaxoSmithKline, Collegeville, PA, USA.
• ¹⁷ Genmab, Copenhagen, Denmark.
• ¹⁸ The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.